No abstract

No abstract

Introduction: Cystic Fibrosis (CF) is a chronic disease which, if left untreated, leads to colonization of the lungs by bacteria and irreversible lung damage. Whilst adherence to nebulized treatments by CF patients is typically poor, evidence suggests that electronic adherence monitoring, combined with treatment-related feedback, may aid patients' ability to adhere. [1] I-neb Insight Online is a telehealth-based patient management system, which incorporates monitoring and feedback. It is designed to support patients in taking an active role in their disease management. Conclusions: I-neb Insight Online provides patients and clinicians with remote access to treatment-related data. The handling study results indicated that the majority of patients found this system to be acceptable and were willing to engage with telehealth-based management. Data summaries and feedback were considered useful by the majority of patients and a high proportion favored continued use of the system; patients particularly valued the opportunity to monitor their own device use. The system has since been made available to all UK patients using the I-neb AAD System and will be available in Europe in the coming months. 1) Nikander, K. et al. Proceedings of Respiratory Drug Delivery. 2012;679-684. 2) Dyche, T. et al. Proceedings of Drug Delivery to the Lungs. 2010;365.